A detailed history of Townsquare Capital LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Townsquare Capital LLC holds 3,705 shares of MRNA stock, worth $247,605. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,705
Previous 2,087 77.53%
Holding current value
$247,605
Previous $222,000 97.75%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $163,757 - $269,574
1,618 Added 77.53%
3,705 $439,000
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $22,452 - $30,360
-263 Reduced 11.19%
2,087 $222,000
Q4 2023

Feb 15, 2024

SELL
$69.51 - $104.43 $19,810 - $29,762
-285 Reduced 10.82%
2,350 $233,000
Q3 2023

Nov 15, 2023

BUY
$96.41 - $126.61 $58,713 - $77,105
609 Added 30.06%
2,635 $272,000
Q2 2023

Nov 13, 2023

BUY
$118.5 - $160.53 $59,368 - $80,425
501 Added 32.85%
2,026 $246,000
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $51,143 - $74,276
-377 Reduced 19.82%
1,525 $234,000
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $225,158 - $399,496
1,902 New
1,902 $341,000
Q2 2022

Aug 08, 2022

SELL
$117.13 - $176.59 $186,002 - $280,424
-1,588 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$126.46 - $235.05 $336,257 - $624,997
-2,659 Reduced 62.61%
1,588 $274,000
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $2.95 Million - $4.81 Million
-13,059 Reduced 75.46%
4,247 $1.08 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $339,950 - $742,208
1,532 Added 9.71%
17,306 $6.66 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $1.48 Million - $2.68 Million
-11,417 Reduced 41.99%
15,774 $3.68 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $943,424 - $1.61 Million
8,641 Added 46.58%
27,191 $3.56 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.22 Million - $3.15 Million
18,550 New
18,550 $1.94 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.